Summary

KEY FINDINGS
The Europe ECG equipment market size is valued at $2,670.35 million as of 2026 and is expected to reach $4,202.25 million by 2034, progressing with a CAGR of 5.83% during the forecast years, 2026-2034.
MARKET INSIGHTS
Cardiovascular disease represents Europe's most pressing health challenge, driving sustained demand for ECG diagnostic equipment across the continent. According to the World Health Organization (WHO) Europe, cardiovascular diseases cause approximately 10,000 deaths daily throughout the European region, accounting for 42.5% of all annual deaths. Furthermore, the European Society of Cardiology (ESC) reports that over 3 million CVD-related deaths occur annually across ESC member countries, representing 37.4% of total mortality.
This substantial disease burden necessitates widespread deployment of cardiology diagnostic equipment throughout healthcare systems. Moreover, aging demographics amplify cardiac monitoring requirements, as cardiovascular disease prevalence increases sharply with age across all European populations. Regional disparities in healthcare access between high-income and middle-income countries create varied equipment adoption patterns.
Additionally, European regulatory frameworks ensure stringent quality standards for medical devices, fostering continuous innovation in digital ECG systems and wireless ECG devices. Healthcare modernization initiatives across EU member states drive the replacement of aging equipment with advanced ECG monitoring systems featuring enhanced connectivity and AI-assisted capabilities.
REGIONAL ANALYSIS
The Europe ECG equipment market growth assessment includes the analysis of the United Kingdom, Germany, France, Italy, Spain, Belgium, Poland, and Rest of Europe.
The United Kingdom presents a mature ECG equipment market shaped by the National Health Service structure and comprehensive cardiovascular disease prevention initiatives. According to UK Government health statistics, approximately 1.88 million people had GP-diagnosed coronary heart disease in England during the financial year ending March 2023. The NHS handles substantial cardiac patient volumes, creating persistent demand for hospital ECG equipment across emergency departments, cardiology units, and general medical wards.
However, hospital admission rates for coronary heart disease have decreased 46% over the past 20 years, reflecting improved preventive care and outpatient management strategies. Consequently, the market exhibits growing adoption of portable ECG monitors, enabling cardiac assessments in community clinics and primary care settings. Furthermore, NHS digital transformation initiatives encourage integration of ECG equipment with electronic health record systems for improved data accessibility. The country's regulatory environment, overseen by the Medicines and Healthcare products Regulatory Agency, maintains high safety and performance standards for cardiac diagnostic equipment.
Additionally, research partnerships between NHS trusts, universities, and medical device manufacturers foster innovation in telecardiology solutions and remote ECG monitoring solutions. Brexit trade arrangements have created new regulatory considerations for medical device importation, though alignment with international standards facilitates continued market access. Private healthcare facilities supplement NHS capacity, particularly in London and major urban centers, purchasing advanced ECG monitoring systems for executive health assessments and specialized cardiac services.
Germany's ECG equipment market demonstrates robust growth supported by advanced healthcare infrastructure, comprehensive insurance coverage, and strong domestic medical technology manufacturing capabilities. The country faces significant cardiovascular disease prevalence, with coronary heart disease affecting 6.0% of men and 3.7% of women according to German health monitoring data. Germany operates a dual healthcare system combining statutory and private insurance, ensuring broad population access to cardiac diagnostic services.
Hospitals across all 16 federal states maintain well-equipped cardiology departments with comprehensive ECG capabilities ranging from basic resting devices to sophisticated stress testing and ambulatory monitoring systems. Moreover, regional variations in cardiovascular disease prevalence between the former East and West Germany territories create differentiated equipment needs. The Robert Koch Institute's health monitoring programs provide detailed epidemiological data informing healthcare planning and equipment procurement decisions. German medical device manufacturers, including established companies with global operations, contribute both to domestic supply and international exports.
Additionally, the country's emphasis on preventive healthcare drives the adoption of routine cardiac screening programs utilizing clinic-based ECG systems. Regulatory oversight through federal health authorities ensures device safety while supporting innovation in AI-assisted ECG interpretation systems and computerized ECG machines. Germany's aging population, ranked third oldest globally, intensifies demand for cardiovascular diagnostic equipment as elderly demographics face elevated heart disease risks.
SEGMENTATION ANALYSIS
The Europe ECG equipment market is segmented into product type, technology, number of leads, portability, application, and end use industry. The technology segment is further categorized into analog and digital.
Digital ECG systems dominate the European market through superior diagnostic capabilities, enhanced connectivity features, and seamless integration with modern healthcare information technology infrastructures. These advanced systems convert cardiac electrical signals into digital formats, enabling sophisticated signal processing, artifact reduction, and precise arrhythmia detection algorithms. Healthcare facilities across Europe are increasingly replacing aging analog equipment with digital ECG systems that offer improved accuracy, data storage capabilities, and remote access functionality.
Furthermore, digital platforms facilitate telemedicine applications essential for extending cardiac care to rural and underserved communities lacking specialized cardiology services. The technology enables real-time ECG monitoring with immediate data transmission to cardiologists regardless of geographic location. Additionally, digital ECG systems integrate smoothly with electronic medical records, eliminating manual data entry errors and improving clinical workflow efficiency. European healthcare providers value the comprehensive reporting features digital systems provide, generating detailed analyses that support evidence-based treatment decisions.
Moreover, these platforms accommodate software updates and feature enhancements without requiring complete hardware replacement, protecting long-term equipment investments. The standardized digital data formats enable interoperability between different healthcare systems and cross-border patient care coordination within the European Union. Cloud-enabled ECG devices leverage digital technology for centralized data management, supporting multi-site healthcare networks and research collaborations. Consequently, the digital segment attracts substantial investment from both healthcare institutions and medical device manufacturers focused on next-generation cardiac diagnostic solutions.
COMPETITIVE INSIGHTS
Some of the top players operating in the Europe ECG equipment market include GE Healthcare, Philips Healthcare, Siemens Healthineers AG, Schiller AG, etc.
Schiller AG maintains a prominent position in the European ECG equipment market through its Swiss-based operations and comprehensive cardiovascular diagnostic product portfolio. The company specializes in developing and manufacturing medical devices for cardiopulmonary diagnostics, defibrillation, and patient monitoring applications serving hospitals, clinics, and physicians worldwide. Schiller's ECG product range encompasses resting systems, stress testing equipment, Holter monitors, and ambulatory blood pressure devices designed for diverse clinical applications.
The CARDIOVIT series represents the company's flagship ECG platform, offering hospital-grade diagnostic accuracy in compact, portable formats suitable for both stationary and mobile use. These systems feature intuitive touchscreen interfaces, integrated interpretation algorithms, and connectivity options supporting modern telemedicine workflows. Furthermore, Schiller maintains manufacturing facilities in Switzerland, France, and Germany, ensuring quality control and proximity to major European markets.
The company's long-standing European heritage, established in 1974, provides a deep understanding of regional regulatory requirements and clinical preferences. Additionally, Schiller operates extensive service networks throughout Europe, delivering installation, training, maintenance, and technical support that strengthen customer relationships and ensure optimal equipment performance. The company's commitment to innovation continues to advance ECG technology while maintaining accessibility for smaller practices and resource-limited healthcare settings across diverse European markets.
COMPANY PROFILES
1. BIONET CO LTD
2. BIOTELEMETRY INC
3. GE HEALTHCARE
4. MCKESSON CORPORATION
5. MINDRAY MEDICAL INTERNATIONAL LIMITED
6. NIHON KOHDEN CORPORATION
7. PHILIPS HEALTHCARE
8. SCHILLER AG
9. SPACELABS HEALTHCARE
10. ZOLL MEDICAL CORPORATION
11. BAXTER

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & FORECAST
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. HOSPITALS REMAIN THE LARGEST END-USERS DUE TO HIGH PROCEDURE VOLUMES AND CRITICAL CARE REQUIREMENTS
2.5.2. PORTABLE AND HANDHELD ECG DEVICES ARE GAINING STRONG ADOPTION IN OUTPATIENT AND HOME CARE SETTINGS
2.5.3. RESTING ECG SYSTEMS CONTINUE TO DOMINATE REVENUE SHARE WHILE AMBULATORY MONITORING SHOWS FASTER GROWTH
2.5.4. EMERGING MARKETS ARE EXPERIENCING RAPID DEMAND GROWTH DRIVEN BY HEALTHCARE INFRASTRUCTURE EXPANSION
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CARDIOVASCULAR DISEASES IS INCREASING DIAGNOSTIC ECG DEMAND GLOBALLY
3.1.2. AGING POPULATIONS ARE DRIVING HIGHER INCIDENCE OF ARRHYTHMIAS AND CHRONIC HEART CONDITIONS
3.1.3. TECHNOLOGICAL ADVANCEMENTS, SUCH AS WIRELESS AND AI-ENABLED ECG SYSTEMS, ARE EXPANDING CLINICAL USE CASES
3.1.4. GROWING FOCUS ON PREVENTIVE HEALTHCARE IS BOOSTING SCREENING AND ROUTINE CARDIAC MONITORING
3.2. KEY RESTRAINTS
3.2.1. HIGH INITIAL COST OF ADVANCED ECG SYSTEMS LIMITS ADOPTION IN SMALL CLINICS AND RURAL SETTINGS
3.2.2. LACK OF SKILLED HEALTHCARE PROFESSIONALS AFFECTS ACCURATE ECG INTERPRETATION IN DEVELOPING REGIONS
3.2.3. STRINGENT REGULATORY APPROVAL PROCESSES CAN DELAY PRODUCT LAUNCHES AND MARKET ENTRY
3.2.4. DATA PRIVACY AND CYBERSECURITY CONCERNS POSE CHALLENGES FOR CONNECTED AND CLOUD BASED ECG DEVICES
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. SHIFT TOWARD PORTABLE AND WEARABLE ECG DEVICES IS TRANSFORMING CARDIAC MONITORING PRACTICES
4.1.2. INTEGRATION OF ARTIFICIAL INTELLIGENCE IS IMPROVING ARRHYTHMIA DETECTION AND DIAGNOSTIC ACCURACY
4.1.3. INCREASING USE OF TELECARDIOLOGY IS EXPANDING ECG ACCESS IN REMOTE AND UNDERSERVED AREAS
4.1.4. MULTIPARAMETER MONITORING SYSTEMS ARE COMBINING ECG WITH OTHER VITAL SIGNS FOR HOLISTIC CARE
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR EUROPE
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
4.6.1. RAW MATERIAL SUPPLIERS
4.6.2. ELECTRONIC COMPONENTS
4.6.3. DEVICE MANUFACTURING
4.6.4. SOFTWARE INTEGRATION
4.6.5. QUALITY TESTING
4.6.6. DISTRIBUTION CHANNELS
4.6.7. END-USER DELIVERY
4.7. KEY BUYING CRITERIA
4.7.1. DIAGNOSTIC ACCURACY
4.7.2. DEVICE PORTABILITY
4.7.3. REGULATORY APPROVAL
4.7.4. TOTAL COST OWNERSHIP
4.8. REGULATORY FRAMEWORK
5. ECG EQUIPMENT MARKET BY PRODUCT TYPE
5.1. RESTING ECG DEVICES
5.1.1. MARKET FORECAST FIGURE
5.1.2. SEGMENT ANALYSIS
5.2. STRESS ECG DEVICES
5.2.1. MARKET FORECAST FIGURE
5.2.2. SEGMENT ANALYSIS
5.3. HOLTER MONITORS
5.3.1. MARKET FORECAST FIGURE
5.3.2. SEGMENT ANALYSIS
5.4. ADVANCED ECG DEVICES
5.4.1. MARKET FORECAST FIGURE
5.4.2. SEGMENT ANALYSIS
5.5. OTHER PRODUCT TYPES
5.5.1. MARKET FORECAST FIGURE
5.5.2. SEGMENT ANALYSIS
6. ECG EQUIPMENT MARKET BY TECHNOLOGY
6.1. ANALOG
6.1.1. MARKET FORECAST FIGURE
6.1.2. SEGMENT ANALYSIS
6.2. DIGITAL
6.2.1. MARKET FORECAST FIGURE
6.2.2. SEGMENT ANALYSIS
7. ECG EQUIPMENT MARKET BY NUMBER OF LEADS
7.1. 1 CHANNEL
7.1.1. MARKET FORECAST FIGURE
7.1.2. SEGMENT ANALYSIS
7.2. 3 CHANNELS
7.2.1. MARKET FORECAST FIGURE
7.2.2. SEGMENT ANALYSIS
7.3. 6 CHANNELS
7.3.1. MARKET FORECAST FIGURE
7.3.2. SEGMENT ANALYSIS
7.4. 12 CHANNELS
7.4.1. MARKET FORECAST FIGURE
7.4.2. SEGMENT ANALYSIS
8. ECG EQUIPMENT MARKET BY PORTABILITY
8.1. STATIONARY
8.1.1. MARKET FORECAST FIGURE
8.1.2. SEGMENT ANALYSIS
8.2. PORTABLE
8.2.1. MARKET FORECAST FIGURE
8.2.2. SEGMENT ANALYSIS
9. ECG EQUIPMENT MARKET BY APPLICATION
9.1. CARDIOVASCULAR DISEASE DIAGNOSIS
9.1.1. MARKET FORECAST FIGURE
9.1.2. SEGMENT ANALYSIS
9.2. ARRHYTHMIA DETECTION
9.2.1. MARKET FORECAST FIGURE
9.2.2. SEGMENT ANALYSIS
9.3. OTHER APPLICATIONS
9.3.1. MARKET FORECAST FIGURE
9.3.2. SEGMENT ANALYSIS
10. ECG EQUIPMENT MARKET BY END USE INDUSTRY
10.1. HOSPITALS
10.1.1. MARKET FORECAST FIGURE
10.1.2. SEGMENT ANALYSIS
10.2. SPECIALTY CLINICS
10.2.1. MARKET FORECAST FIGURE
10.2.2. SEGMENT ANALYSIS
10.3. AMBULATORY SURGICAL CENTRES
10.3.1. MARKET FORECAST FIGURE
10.3.2. SEGMENT ANALYSIS
10.4. OTHER END USE INDUSTRIES
10.4.1. MARKET FORECAST FIGURE
10.4.2. SEGMENT ANALYSIS
11. GEOGRAPHICAL ANALYSIS
11.1. EUROPE
11.1.1. MARKET SIZE & ESTIMATES
11.1.2. EUROPE MARKET DRIVERS
11.1.3. EUROPE MARKET CHALLENGES
11.1.4. KEY PLAYERS IN EUROPE ECG EQUIPMENT MARKET
11.1.5. COUNTRY ANALYSIS
11.1.5.1. GERMANY
11.1.5.1.1. GERMANY MARKET SIZE & OPPORTUNITIES
11.1.5.2. UNITED KINGDOM
11.1.5.2.1. UNITED KINGDOM MARKET SIZE & OPPORTUNITIES
11.1.5.3. FRANCE
11.1.5.3.1. FRANCE MARKET SIZE & OPPORTUNITIES
11.1.5.4. ITALY
11.1.5.4.1. ITALY MARKET SIZE & OPPORTUNITIES
11.1.5.5. SPAIN
11.1.5.5.1. SPAIN MARKET SIZE & OPPORTUNITIES
11.1.5.6. BELGIUM
11.1.5.6.1. BELGIUM MARKET SIZE & OPPORTUNITIES
11.1.5.7. POLAND
11.1.5.7.1. POLAND MARKET SIZE & OPPORTUNITIES
11.1.5.8. REST OF EUROPE
11.1.5.8.1. REST OF EUROPE MARKET SIZE & OPPORTUNITIES
12. COMPETITIVE LANDSCAPE
12.1. KEY STRATEGIC DEVELOPMENTS
12.1.1. MERGERS & ACQUISITIONS
12.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
12.1.3. PARTNERSHIPS & AGREEMENTS
12.1.4. BUSINESS EXPANSIONS & DIVESTITURES
12.2. COMPANY PROFILES
12.2.1. BIONET CO LTD
12.2.1.1. COMPANY OVERVIEW
12.2.1.2. PRODUCT LIST
12.2.1.3. STRENGTHS & CHALLENGES
12.2.2. BIOTELEMETRY INC
12.2.2.1. COMPANY OVERVIEW
12.2.2.2. PRODUCT LIST
12.2.2.3. STRENGTHS & CHALLENGES
12.2.3. GE HEALTHCARE
12.2.3.1. COMPANY OVERVIEW
12.2.3.2. PRODUCT LIST
12.2.3.3. STRENGTHS & CHALLENGES
12.2.4. MCKESSON CORPORATION
12.2.4.1. COMPANY OVERVIEW
12.2.4.2. PRODUCT LIST
12.2.4.3. STRENGTHS & CHALLENGES
12.2.5. MINDRAY MEDICAL INTERNATIONAL LIMITED
12.2.5.1. COMPANY OVERVIEW
12.2.5.2. PRODUCT LIST
12.2.5.3. STRENGTHS & CHALLENGES
12.2.6. NIHON KOHDEN CORPORATION
12.2.6.1. COMPANY OVERVIEW
12.2.6.2. PRODUCT LIST
12.2.6.3. STRENGTHS & CHALLENGES
12.2.7. PHILIPS HEALTHCARE
12.2.7.1. COMPANY OVERVIEW
12.2.7.2. PRODUCT LIST
12.2.7.3. STRENGTHS & CHALLENGES
12.2.8. SCHILLER AG
12.2.8.1. COMPANY OVERVIEW
12.2.8.2. PRODUCT LIST
12.2.8.3. STRENGTHS & CHALLENGES
12.2.9. SPACELABS HEALTHCARE (SUBSIDIARY OF OSI SYSTEMS INC)
12.2.9.1. COMPANY OVERVIEW
12.2.9.2. PRODUCT LIST
12.2.9.3. STRENGTHS & CHALLENGES
12.2.10. ZOLL MEDICAL CORPORATION (ACQUIRED BY ASAHI KASEI)
12.2.10.1. COMPANY OVERVIEW
12.2.10.2. PRODUCT LIST
12.2.10.3. STRENGTHS & CHALLENGES
12.2.11. BAXTER
12.2.11.1. COMPANY OVERVIEW
12.2.11.2. PRODUCT LIST
12.2.11.3. STRENGTHS & CHALLENGES



LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - ECG EQUIPMENT
TABLE 2: ECG EQUIPMENT MARKET REGULATORY FRAMEWORK
TABLE 3: MARKET BY PRODUCT TYPE, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 4: MARKET BY PRODUCT TYPE, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 5: MARKET BY TECHNOLOGY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 6: MARKET BY TECHNOLOGY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 7: MARKET BY NUMBER OF LEADS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 8: MARKET BY NUMBER OF LEADS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 9: MARKET BY PORTABILITY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 10: MARKET BY PORTABILITY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 12: MARKET BY APPLICATION, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 13: MARKET BY END USE INDUSTRY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 14: MARKET BY END USE INDUSTRY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 15: EUROPE MARKET, COUNTRY ANALYSIS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 16: EUROPE MARKET, COUNTRY ANALYSIS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 17: KEY PLAYERS OPERATING IN THE EUROPEAN MARKET
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR EUROPE
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: SEGMENT GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2025
FIGURE 9: RESTING ECG DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 10: STRESS ECG DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 11: HOLTER MONITORS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 12: ADVANCED ECG DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 13: OTHER PRODUCT TYPES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 14: SEGMENT GROWTH POTENTIAL, BY TECHNOLOGY, IN 2025
FIGURE 15: ANALOG MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 16: DIGITAL MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 17: SEGMENT GROWTH POTENTIAL, BY NUMBER OF LEADS, IN 2025
FIGURE 18: 1 CHANNEL MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 19: 3 CHANNELS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 20: 6 CHANNELS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 21: 12 CHANNELS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 22: SEGMENT GROWTH POTENTIAL, BY PORTABILITY, IN 2025
FIGURE 23: STATIONARY MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 24: PORTABLE MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 25: SEGMENT GROWTH POTENTIAL, BY APPLICATION, IN 2025
FIGURE 26: CARDIOVASCULAR DISEASE DIAGNOSIS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 27: ARRHYTHMIA DETECTION MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 28: OTHER APPLICATIONS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 29: SEGMENT GROWTH POTENTIAL, BY END USE INDUSTRY, IN 2025
FIGURE 30: HOSPITALS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 31: SPECIALTY CLINICS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 32: AMBULATORY SURGICAL CENTRES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 33: OTHER END USE INDUSTRIES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 34: EUROPE ECG EQUIPMENT MARKET, COUNTRY OUTLOOK, 2025 & 2034 (IN %)
FIGURE 35: GERMANY MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 36: UNITED KINGDOM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 37: FRANCE MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 38: ITALY MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 39: SPAIN MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 40: BELGIUM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 41: POLAND MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 42: REST OF EUROPE MARKET SIZE, 2026-2034 (IN $ MILLION)

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - ECG EQUIPMENT
TABLE 2: ECG EQUIPMENT MARKET REGULATORY FRAMEWORK
TABLE 3: MARKET BY PRODUCT TYPE, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 4: MARKET BY PRODUCT TYPE, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 5: MARKET BY TECHNOLOGY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 6: MARKET BY TECHNOLOGY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 7: MARKET BY NUMBER OF LEADS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 8: MARKET BY NUMBER OF LEADS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 9: MARKET BY PORTABILITY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 10: MARKET BY PORTABILITY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 12: MARKET BY APPLICATION, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 13: MARKET BY END USE INDUSTRY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 14: MARKET BY END USE INDUSTRY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 15: EUROPE MARKET, COUNTRY ANALYSIS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 16: EUROPE MARKET, COUNTRY ANALYSIS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 17: KEY PLAYERS OPERATING IN THE EUROPEAN MARKET
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES